Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven Grant

Showing results (51-60 of 386) with videos related to

Pageof 39
Sort By:
The Journal of Clinical Investigation|March 20, 2002
A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKCdelta?Steven Grant, Sarah Spiegel
Critical Reviews in Eukaryotic Gene Expression|August 4, 2012
Targeting the regulatory machinery of BIM for cancer therapyHisashi Harada, Steven Grant
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 26, 2003
The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapySteven Grant, John D Roberts
Expert Opinion on Investigational Drugs|May 5, 2015
Romidepsin for the treatment of non-Hodgkin's lymphomaVictor Y Yazbeck, Steven Grant
Expert Opinion on Investigational Drugs|December 19, 2003
Histone deacetylase inhibitors in clinical developmentRoberto R Rosato, Steven Grant
Molecular Cancer Therapeutics|December 24, 2013
Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanismTri K Nguyen, Steven Grant
Plos One|April 4, 2019
Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella speciesSteven Grant Waldrop, Nammalwar Sriranganathan
Expert Opinion on Therapeutic Targets|August 9, 2005
Histone deacetylase inhibitors: insights into mechanisms of lethalityRoberto R Rosato, Steven Grant
Cancer Biology & Therapy|April 4, 2003
Histone deacetylase inhibitors in cancer therapyRoberto R Rosato, Steven Grant
Experimental Cell Research|June 14, 2002
The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated processMohamed Rahmani, Yun Dai, Steven Grant
Pageof 39

Showing results (51-60 of 386) with videos related to

Sort By:
Pageof 39
The Journal of Clinical Investigation|March 20, 2002
A chicken-or-egg conundrum in apoptosis: which comes first? Ceramide or PKCdelta?Steven Grant, Sarah Spiegel
Critical Reviews in Eukaryotic Gene Expression|August 4, 2012
Targeting the regulatory machinery of BIM for cancer therapyHisashi Harada, Steven Grant
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|March 26, 2003
The use of cyclin-dependent kinase inhibitors alone or in combination with established cytotoxic drugs in cancer chemotherapySteven Grant, John D Roberts
Expert Opinion on Investigational Drugs|May 5, 2015
Romidepsin for the treatment of non-Hodgkin's lymphomaVictor Y Yazbeck, Steven Grant
Expert Opinion on Investigational Drugs|December 19, 2003
Histone deacetylase inhibitors in clinical developmentRoberto R Rosato, Steven Grant
Molecular Cancer Therapeutics|December 24, 2013
Dinaciclib (SCH727965) inhibits the unfolded protein response through a CDK1- and 5-dependent mechanismTri K Nguyen, Steven Grant
Plos One|April 4, 2019
Intracellular invasion and survival of Brucella neotomae, another possible zoonotic Brucella speciesSteven Grant Waldrop, Nammalwar Sriranganathan
Expert Opinion on Therapeutic Targets|August 9, 2005
Histone deacetylase inhibitors: insights into mechanisms of lethalityRoberto R Rosato, Steven Grant
Cancer Biology & Therapy|April 4, 2003
Histone deacetylase inhibitors in cancer therapyRoberto R Rosato, Steven Grant
Experimental Cell Research|June 14, 2002
The histone deacetylase inhibitor sodium butyrate interacts synergistically with phorbol myristate acetate (PMA) to induce mitochondrial damage and apoptosis in human myeloid leukemia cells through a tumor necrosis factor-alpha-mediated processMohamed Rahmani, Yun Dai, Steven Grant
Pageof 39